Tevfik Güzelbey

Tevfik Güzelbey

Auto-generated profile, based on publicly available information

Tevfik Güzelbey

Department of Nuclear Medicine, Başakşehir Cam and Sakura City Hospital, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2024 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
ADAli Dablan
Ali Dablan
ÇEÇağrı Erdim
Çağrı Erdim
TGTevfik Güzelbey
Tevfik Güzelbey
MCMehmet Cingöz
Mehmet Cingöz
MAMustafa Fatih Arslan
Mustafa Fatih Arslan
ÖKÖzgür Kılıçkesmez
Özgür Kılıçkesmez

19 August 2024 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
TGTevfik Guzelbey
Tevfik Guzelbey
ADAli Dablan
Ali Dablan
CECagri Erdim
Cagri Erdim
RDRabia Deniz
Rabia Deniz
IMIlhan nahit Mutlu
Ilhan nahit Mutlu
OKOzgur Kilickesmez
Ozgur Kilickesmez

24 May 2024 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
ÖKÖzgür Kılıçkesmez
Özgür Kılıçkesmez
ADAli Dablan
Ali Dablan
TGTevfik Güzelbey
Tevfik Güzelbey
MCMehmet Cingöz
Mehmet Cingöz
IMIlhan nahit Mutlu
Ilhan nahit Mutlu

27 November 2018 in Radiology Case Reports
Verified
Journal Article
Open access
PDF file
MÇMehmet Semih Çakır
Mehmet Semih Çakır
TGTevfik Guzelbey
Tevfik Guzelbey
EKERDEM KINACI
ERDEM KINACI
MSMert Mahsuni Sevinc
Mert Mahsuni Sevinc
OKOzgur Kilickesmez
Ozgur Kilickesmez
Bilhemia is very rare and serious complication of percutaneous transhepatic biliary drainage (PBD). Bile leakage occurs into the bloodstream through a fistula between the biliary tree and the hepatic venous system. We report a case of a 45-year-old woman with bilhemia complicated by PBD. She was successfully treated with primary coil embolization of biliovenous fistula tract. In the follow-up, bilirubin values dramatically regressed and returned to its normal limits. Rapid increase in total and direct bilirubin values after PBD without biliary tree dilatation almost always suggest biliovenous fistula. It is more likely that biliovenous fistulas will develop in catheters that are removed before the time of the tract maturation. Symptomatic bilhemia should be treated as soon as possible to prevent major complications like bile pulmonary embolism and biliary sepsis.

4 August 2025 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
ADAli Dablan
Ali Dablan
HÖHamit Özgül
Hamit Özgül
MAMustafa Fatih Arslan
Mustafa Fatih Arslan
OTOğuzhan Türksayar
Oğuzhan Türksayar
MCMehmet Cingöz
Mehmet Cingöz
OKOzgur Kılıckesmez
Ozgur Kılıckesmez

27 October 2023 in Journal of Vascular Surgery: Venous and Lymphatic Disorders
Verified
Journal Article
Open access
TGTevfik Guzelbey
Tevfik Guzelbey
MCMehmet Cingoz
Mehmet Cingoz
CECagri Erdim
Cagri Erdim
IMIlhan nahit Mutlu
Ilhan nahit Mutlu
OKOzgur Kılıckesmez
Ozgur Kılıckesmez
The objective of this study was to retrospectively evaluate the effectiveness of polidocanol in managing pain, swelling, functional limiting and cosmetic disorders in patients with venous malformations (VMs). This retrospective study included patients who underwent sclerotherapy with polidocanol for VMs between 2020 and 2022. Patient records, imaging findings, and evaluation questionnaires used in the preprocedure and follow-up phases were reviewed. After sclerotherapy, patients were followed up at 1, 2, 3, and 6 months. During these visits, the previously used 11-point verbal numerical rating scale (from 0 [no pain] to 10 [worst pain thinkable]) was used to evaluate the severity of symptoms such as pain, swelling, cosmetic discomfort, and functional limitation, and patients were asked to report the number of days per week they experienced these symptoms owing to the VM. A total of 194 sclerotherapy procedures (mean, 1.6 ± 0.3 procedures) in 84 patients (55 female and 29 male patients; mean age, 22.45 ± 11.83 years) were conducted. The majority of these malformations (81%, or 68 patients) were located in the extremities. We found a significant decrease in pain, swelling, functional limitation, cosmetic appearance, and number of painful days between all time points, except for the comparison between months 3 and 6 (P < .001) CONCLUSIONS: Polidocanol sclerotherapy is a safe and effective treatment for VMs that significantly decreases patient complaints and has a very low complication rate. Particularly, following patients at short intervals and administering additional sclerotherapy sessions when necessary will significantly increase patient satisfaction.